Cargando…
Proposal of a study protocol of a preliminary double-blind randomized controlled trial. Verifying effects of selenium supplementation on selenoprotein p and s genes expression in protein and mRNA levels in subjects with coronary artery disease: selenegene study
Background: Selenium is the component of selenocystein amino acid, which itself is the building block of selenoproteins having diverse effects on various aspects of the human health. Among these proteins, selenoprotein P is the central to the distribution and homeostasis of selenium, and selenoprote...
Autores principales: | Mojgan, Gharpour, Masoumeh, Sadeghi, Mehrdad, Behmanesh, Mansour, Salehi, Hamidreza, Roohafza, Pouya, Nezafati, Elham, Khosravi, Mohsen, Hosseini, Mahtab, Keshvari, Hojat, Rouhi-Bourojeni, Nizal, Sarrafzadegan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502150/ https://www.ncbi.nlm.nih.gov/pubmed/30889154 http://dx.doi.org/10.23750/abm.v90i1.6167 |
Ejemplares similares
-
Effects of selenium supplementation on paraoxonase-1 and myeloperoxidase activity in subjects with cardiovascular disease: the Selenegene study, a double-blind randomized controlled trial
por: Mirmohammadsadeghi, Amirhossein, et al.
Publicado: (2018) -
Selenium homeostasis and clustering of cardiovascular risk factors: a systematic review
por: Gharipour, Mojgan, et al.
Publicado: (2017) -
Cardiovascular Disease Risk Assessment: Triglyceride/High-Density Lipoprotein versus Metabolic Syndrome Criteria
por: Gharipour, Mojgan, et al.
Publicado: (2019) -
Socioeconomic characteristics and controlled hypertension:
Evidence from Isfahan Healthy Heart Program
por: Gharipour, Mojgan, et al.
Publicado: (2013) -
Effects of selenium intake on the expression of prostaglandin-endoperoxide synthase 2 (cyclooxygenase-2) and matrix metallopeptidase-9 genes in the coronary artery disease: Selenegene study, a double-blind randomized controlled trial
por: Gharipour, Mojgan, et al.
Publicado: (2021)